Date: August 12, 2020 Source 1: Harvard Medical School Source 2: www.sciencedaily.com Summary: New drug regimen for multidrug-resistant tuberculosis shows early effectiveness in 85 percent of patients in a cohort including many with serious comorbidities. The results suggest a global need for expanded access to two recently developed medicines, bedaquiline and delamanid. Study cohort included […]
Date: August 11, 2020 Source 1: University of California, San Francisco Source 2: www.sciencedaily.com Summary: Scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes COVID-19. The researchers engineered a completely synthetic, production-ready molecule that straitjackets the crucial SARS-CoV-2 machinery that allows the virus to infect our cells. In
Date: August 10, 2020 Source 1: Ruhr-University Bochum Source 2: www.sciencedaily.com Summary: Results from cell culture experiments show that commercially available preparations have an effect on Sars-Cov-2 viruses. Sars-Cov-2 viruses can be inactivated using certain commercially available mouthwashes. This was demonstrated in cell culture experiments by virologists from Ruhr-Universität Bochum together with colleagues from Jena,
